Moderna Therapeutics

About Moderna Therapeutics

Moderna Therapeutics is a pioneering biotechnology company based in the UK, dedicated to transforming the field of medicine through innovative mRNA technology. Founded with the vision of harnessing the power of messenger RNA (mRNA) to create a new class of transformative medicines, Moderna is at the forefront of developing vaccines and therapeutics for infectious diseases, cancer, and rare diseases.

The company’s flagship product, the COVID-19 vaccine, has played a crucial role in the global response to the pandemic, showcasing the potential of mRNA technology in rapidly addressing public health crises. Moderna’s commitment to research and development is evident in its robust pipeline, which includes multiple candidates in various stages of clinical trials.

At Moderna, collaboration is key. The company partners with leading academic institutions, government agencies, and other biotech firms to accelerate the development of its therapies. This collaborative approach not only enhances innovation but also ensures that the latest scientific advancements are integrated into their product development processes.

Moderna is also deeply committed to sustainability and ethical practices, striving to minimize its environmental impact while ensuring access to its life-saving therapies worldwide. The company believes in the importance of transparency and actively engages with stakeholders to foster trust and accountability.

As a leader in the biotechnology sector, Moderna Therapeutics continues to push the boundaries of science, aiming to deliver on its promise of creating a healthier future for all. With a dedicated team of scientists, researchers, and professionals, Moderna is well-positioned to lead the next wave of medical breakthroughs.

• Core Activities: Development of mRNA-based vaccines and therapeutics.
• Vision: To revolutionise medicine through innovative mRNA technology.
• Commitment: Focus on sustainability and ethical practices.